I . DNA synthesis in the bone marrow and lymphocytes of the vitamin B,,-deficient fruit bat (Rosetrus Aegyptiucw) has been studied via the deoxyuridine (dU) suppression test.
Experimental animals
Fruit bats were captured in the wild and were maintained on a pest-free, all-fruit diet . On this diet, liver vitamin B,, stores decrease exponentially with a half-life of 109 d. Control animals were maintained on an identical diet, but received 500 ng cyanocobalamin by injection every 2 weeks. At the time of study, the mean serum vitamin B,, concentration in the control bats, measured by radioisotope dilution assay using chicken serum as the vitamin B,,-binding protein , ranged from 743 to zooopg/ml (mean 1418pg/ml) and in the deficient bats, < I O to 267 pg/ml (mean I 14 pg/ml). All the deficient bats showed neurological impairment as manifested by difficulty in climbing and changes in the normal flying cycle. These changes did not occur in the bats receiving vitamin B,, supplements.
Both bone marrow and lymphocytes were studied, the latter because blood could be obtained without killing the bats. [aH] thymidine (3H-TdR) (specific activity I 5-20 Ci/mmol) was obtained from The Radiochemical Centre, Amersham, Bucks. Phytohaemagglutinin (PHA) was purchased from Wellcome Laboratories, methotrexate (MTX) from Lederle Laboratories, dU from Sigma Laboratories, cyanocobalamin from Glaxo Laboratories, and folic acid (pteroylglutamic acid) from Sigma Laboratories.
Radioactive and non-radioactive compounds
Bone marrow culture Bats were killed by exsanguination via cardiac puncture. The humerus bones were removed immediately after death. Marrow was flushed from these bones by injecting 2 ml culture medium TCrgg (Wellcome Laboratories) via a 26 gauge needle through the marrow cavity.
All subsequent preparative procedures were carried out in the cold. The suspension of marrow cells was washed twice with 4 ml culture medium, centrifuging each time at 400g for 15 min at 4". A final suspension of concentration 2 x io%ells/ml was prepared in culture medium, comprising TC1gg and foetal calf serum (FCS) (2: I, v/v).
For the individual experiments, 0.2 ml cell suspension containing 4 x 1oS cells was pipetted into each well of a microtitre plate. All cultures were set up in triplicate. The plates were incubated in sealed boxes in which the atmosphere was kept moist.
After incubation with various additives, according to the individual experiments, the reactions were terminated by harvesting the cells on paper (Skatron AS) in a Titetek harvester. The discs were cut out of the paper, and placed in plastic disposable vials containing 4ml toluene. Scintillation fluid was added, and the radioactivity assayed in a Packard Liquid-Scintillation counter.
Lymphocyte culture Blood was drawn by cardiac puncture, and 5 ml was layered carefully onto a Hypaque-Ficoll gradient. The gradient was centrifuged at 600g for 30 min at 18". The lymphocyte layer was removed with a pipette and washed twice in 15 ml T C I~~, centrifuging each time at 600g for 10 min at 18". The cells were resuspended at a concentration of I x Io6/ml medium containing FCS (250 mg/ml).
Preliminary experiments were carried out to determine the concentration of PHA which would produce optimum stimulation of bat lymphocytes. Concentrations of PHA ranging from 5 to 5opg/Io5 cells were added to the lymphocyte suspensions, which were then incubated for 48 h at 37". The uptake of 3H-TdR after a further 24 h incubation was determined. The uptake of 3H-TdR was maximal at a concentration of 10 pg PHA/ro5 cells in the DNA in B12-deficient bats 231 lymphocytes from both control and deficient bats. All subsequent experiments were carried out using this concentration of PHA.
Portions of 0.2 ml containing 2 x 1 0 5 cells were pipetted into each well of a microtitre plate, and 20pg PHA added to each well. Controls comprised cells only, without added PHA. All cultures were set up in triplicate. The plates were incubated for 48 h, under the same conditions as described for the bone marrow cultures. After 48 h incubation, various compounds were added, as detailed in the individual experiments, and the cultures reincubated. At the end of the experiments, the lymphocytes were harvested and the radioactivity assayed as described for the bone marrow cultures.
As the number of cells/well in the marrow cultures (4x 1 0~) was double that for the lymphocyte cultures (2 x 103, the amount of additives used was always halved for the latter.
The dU suppression test The test was carried out in bone marrow and lymphocyte cultures by standard techniques (Metz ei al. 1968; Das & Hornrand, 1970) . Three different concentrations of dU were used, 0-1, 0.01, and 0001 p~. Each concentration was added in a volume of 10 pl. In the instance of lymphocyte cultures, the dU was added in concentrations of 0.1, 0.01, and 0.001 ,m/well after the cultures had been incubated for 48 h with PHA, and the cultures then incubated for I h at 37". 8H-TdR (0.2 pCi in 10 pl) was then added, and the cells incubated for a further 24 h before harvesting.
In bone marrow suspensions, the dU in concentrations of 0-2, 0.02, and 0.002 pM/Well was added and the cultures then stood for 30 min at room temperature. 3H-TdR (04 pCi in 1op1) was then added to each well, and the cells incubated for a further 2 h at 37".
Control cultures were kept at 4" for 2 h.
Efect of methotrexate, cyanocobalamin and folic acid on dU suppression
When the effect of these compounds on dU suppression was studied, they were added to the cultures in 10 pl volumes before adding the dU. In the bone marrow cultures, the cells were then incubated for 15 min at room temperature, the dU added, and the dU suppression test completed as described previously. The lymphocyte cultures were incubated at 37" for 30 min, the dU then added and the test completed as described previously.
RESULTS

Bone marrow
The dU suppression test was carried out on five control and five deficient bats. As all cultures were set up in triplicate, the number of cells obtained was not always adequate to perform the test at all three concentrations of dU. When limited numbers of cells were available, the higher concentrations of dU received priority.
The results are shown in Table I . In control bats, pre-incubation of marrow cells with dU suppressed the uptake of subsequently added 3H-TdR and the effect was dose dependent. Expressed as a percentage of the control sample without dU, uptake was suppressed to mean values of 5.0, 23-2, and 45.0 at concentrations of dU of 0-2, 002, and 0-002 pu respectively. In the vitamin BIB-deficient bats, the dU suppression was slightly more than in the control animals, but the differences are not statistically significant.
Lymphocytes
The results of dU suppression tests carried out at various concentrations of dU in six control and ten deficient bats are shown in Table 2 . The results are similar to those found deoxyuridine (dU) suppression test in bone marrow from vitamin B,,-replete and  vitamin B,,-deficient -stimulated lymphocytes from vitamin  B,,-replete and vitamin B,,- 
Efect of methotrexate
The effect of MTX on dU suppression at two dose levels of dU (0.2 and 0 -0 2~~) was studied in bone marrow from four bats. The results are shown in Table 3 . In all the experiments, MTX markedly inhibited the ability of dU to suppress the uptake of subsequently added 3H-TdR.
DISCUSSION
In the present study, pre-incubation of cultures of bat bone marrow or lymphocytes with dU produced suppression of the uptake of subsequently added 8H-TdR. This action of dU is similar to that found in human bone marrow and lymphocytes, indicating the presence of de novo pathways for DNA synthesis in the bat cells. As in man, the de novo pathway is dependent on a supply of reduced folate, for MTX inhibits markedly the ability of dU to suppress the uptake of 3H-TdR.
In vitamin B1, deficiency in man, dU fails to suppress the uptake of subsequently added 3H-TdR, and there is a clear difference between healthy subjects and vitamin B,,-deficient patients (Metz et al. 1968 ; Das & Hoffbrand, 1970; ). Abnormal DNA synthesis in vitamin B,, deficiency in man is attributed to impairment of thymidylate synthesis via the de novo pathway. The defect is partially corrected by the addition of vitamin BL2, but corrected completely by the addition of non-methylated folate (Metz et al. 1968 ; van der Weyden et al. 1973; Zittoun et al. 1973 ). Thus vitamin B12 deficiency is thought to produce its effect on DNA synthesis via a secondary derangement in folate metabolism. The most widely held explanation for this is the methylfolate trap hypothesis, whereby decreased activity of the vitamin B,,-dependent enzyme methionine synthetase (EC 2. I . I . I 3) necessary for the conversion of methylfolate to tetrahydrofolate (THFA) results in deficient THFA for de novo synthesis of thymine DNA (Herbert & Zalusky, 1962 ; Noronha & Silverman, 1962) . Further evidence in favour of trapping of methylfolate is the rise in serum folate (largely methylfolate) levels that occurs in vitamin B,, deficiency in man.
In the fruit bat, no significant difference could be demonstrated between vitamin B,,deficient and control animals, in spite of very low levels of serum vitamin BIB and severe neurological changes in the deficient bats. The failure of vitamin B12 deficiency in the bat to lead to changes in the dU suppression test as seen in vitamin B,,-deficient man may be due to a number of factors. It is possible that in the bat, the conversion of methylfolate to 234 HEDVA MILLER, F. FERNANDES-COSTA AND J. METZ THFA is not vitamin B,,-dependent. However, the finding that serum folate levels are elevated in the vitamin B,,-deficient bat suggests that the reaction is in fact vitamin B,,-dependent. Furthermore, methionine synthetase activity in the liver of vitamin BIZ-deficient bats is significantly reduced compared with that of control bats (I. Chanarin & J. Perry, unpublished observations). Thus it is unlikely that failure to demonstrate a defect in DNA synthesis in the vitamin B,,-deficient bat is due to the fact that the enzyme methionine synthetase is not vitamin Bl,-dependent.
The results of other studies in the bat suggest a more likely explanation for the present findings. Perry er al. (1979~2, b) demonstrated significan differences in the way injected labelled methylfolate and THFA are used by the bat. The results suggest the presence of two distinct pools of folate activity, the methylfolate pool being separate from the THFA pool, and not a single pool as previously supposed. If, as indicated from this work, the THFA is distinct from the methylfolate pool, it would suggest a source of THFA for haemopoeisis for the bat, which is not dependent on constant regeneration of THFA from methylfolate. This would provide the bat with an escape mechanism whereby the effect of trapping of methylfolate in vitamin B,, deficiency could be overcome via the separate THFA pool.
The vitamin B,,-deficient all-fruit diet fed to the bats is high in folate, and the initial rise in red cell folate levels in the bats during captivity (van Tonder er al. 1975) may be a reflexion of this. The high dietary folate intake may be a factor in protecting haemopoeisis from megaloblastic change in vitamin B,, deficiency, and as such these bats would resemble human vegans with a low vitamin B,,-high folate diet, and in whom vitamin B,, deficiency leads to more severe neurological than haematological changes (Wokes & Smith, 1962) . However, this is unlikely to be the only reason for the absence of megaloblastic change in the bat, for some human vegans do develop megaloblastic change due to vitamin B,, deficiency (Mollin & Ross, 1954) .
Secondary changes in the concentration of serum transcobalamins which occur in the vitamin B,,-deficient bat, but not in vitamin B,,-deficient man, may be of relevance in protecting the vitamin B,,-deficient bat from developing megaloblastic anaemia. As vitamin B,, deficiency develops in the bat fed on the all-fruit diet, the levels of transcobalamin I1 (TCII), the transport binder which promotes cellular uptake of vitamin Blz, rises markedly (Green et al. 1979) . Such a rise does not occur in vitamin B,,-deficient man (Retief et al. 1967) . As suggested by Green et al. (1979)~ this change in TCII could represent a compensatory adjustment to the lowered state of vitamin B,, nutrition in the bat. However, this change is unlikely to afford protection for haemopoiesis at the very low levels of serum vitamin B,, that occurred in some of the vitamin B,,-deficient bats in this study.
The findings of the present study reinforce the concept that the defect in de novo synthesis of DNA, as demonstrated via the dU suppression test, is the central theme in considering the mechanism whereby vitamin B,, deficiency leads to megaloblastic anaemia.
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